Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • IGC Pharma
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance

IGC Files Patent for Hyalolex Formulation

April 10, 2018September 10, 2019 by charlie
Posted in News and Filings, Press Releases

Post navigation

← IGC Partners to Launch Hyalolex in Puerto Rico
IGC Radica Patente para la Fórmula Hyalolex →

Site Map

  • Home
  • IGC Pharma
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance

Contact

India Globalization Capital
Potomac, MD, United States

info@igcinc.us
301-983-0998